Report Detail
Global Oral Vaccines Market Insights, Forecast to 2025
- RnM3087718 |
- 09 March, 2019 |
- Global |
- 123 Pages |
- QYResearch |
- Pharma & Healthcare
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
In the last several years, global market of oral vaccines developed rapidly, with an average growth rate of 6.31%. In 2017, global revenue of oral vaccines is nearly 2.01 billion USD; the actual consumption is about 2.2 billion doses.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine in 2017 is about 94%, and the proportion is in decreasing trend from 2012 to 2017.
The global Oral Vaccines market is valued at 2010 million US$ in 2018 and will reach 3480 million US$ by the end of 2025, growing at a CAGR of 7.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oral Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Oral Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oral Vaccines in these regions.
This research report categorizes the global Oral Vaccines market by top players/brands, region, type and end user. This report also studies the global Oral Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market size by Product
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Others
Market size by End User
Public
Private
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Oral Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Oral Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oral Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Oral Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Oral Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Oral Vaccines Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Oral Vaccines Market Size Growth Rate by Product
- 1.4.2 Rotavirus Vaccine
- 1.4.3 Cholera Vaccine
- 1.4.4 Oral Polio Vaccine
- 1.4.5 Others
- 1.5 Market by End User
- 1.5.1 Global Oral Vaccines Market Size Growth Rate by End User
- 1.5.2 Public
- 1.5.3 Private
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Oral Vaccines Market Size
- 2.1.1 Global Oral Vaccines Revenue 2014-2025
- 2.1.2 Global Oral Vaccines Sales 2014-2025
- 2.2 Oral Vaccines Growth Rate by Regions
- 2.2.1 Global Oral Vaccines Sales by Regions
- 2.2.2 Global Oral Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Oral Vaccines Sales by Manufacturers
- 3.1.1 Oral Vaccines Sales by Manufacturers
- 3.1.2 Oral Vaccines Sales Market Share by Manufacturers
- 3.1.3 Global Oral Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.2 Oral Vaccines Revenue by Manufacturers
- 3.2.1 Oral Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 Oral Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.3 Oral Vaccines Price by Manufacturers
- 3.4 Oral Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 Oral Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Oral Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into Oral Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Oral Vaccines Sales by Product
- 4.2 Global Oral Vaccines Revenue by Product
- 4.3 Oral Vaccines Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Oral Vaccines Breakdown Data by End User
6 North America
- 6.1 North America Oral Vaccines by Countries
- 6.1.1 North America Oral Vaccines Sales by Countries
- 6.1.2 North America Oral Vaccines Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Oral Vaccines by Product
- 6.3 North America Oral Vaccines by End User
7 Europe
- 7.1 Europe Oral Vaccines by Countries
- 7.1.1 Europe Oral Vaccines Sales by Countries
- 7.1.2 Europe Oral Vaccines Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Oral Vaccines by Product
- 7.3 Europe Oral Vaccines by End User
8 Asia Pacific
- 8.1 Asia Pacific Oral Vaccines by Countries
- 8.1.1 Asia Pacific Oral Vaccines Sales by Countries
- 8.1.2 Asia Pacific Oral Vaccines Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Oral Vaccines by Product
- 8.3 Asia Pacific Oral Vaccines by End User
9 Central & South America
- 9.1 Central & South America Oral Vaccines by Countries
- 9.1.1 Central & South America Oral Vaccines Sales by Countries
- 9.1.2 Central & South America Oral Vaccines Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Oral Vaccines by Product
- 9.3 Central & South America Oral Vaccines by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Oral Vaccines by Countries
- 10.1.1 Middle East and Africa Oral Vaccines Sales by Countries
- 10.1.2 Middle East and Africa Oral Vaccines Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Oral Vaccines by Product
- 10.3 Middle East and Africa Oral Vaccines by End User
11 Company Profiles
- 11.1 Merck
- 11.1.1 Merck Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Merck Oral Vaccines Products Offered
- 11.1.5 Merck Recent Development
- 11.2 GSK
- 11.2.1 GSK Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GSK Oral Vaccines Products Offered
- 11.2.5 GSK Recent Development
- 11.3 Sanofi
- 11.3.1 Sanofi Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sanofi Oral Vaccines Products Offered
- 11.3.5 Sanofi Recent Development
- 11.4 Lanzhou Institute
- 11.4.1 Lanzhou Institute Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Lanzhou Institute Oral Vaccines Products Offered
- 11.4.5 Lanzhou Institute Recent Development
- 11.5 Serum Institute
- 11.5.1 Serum Institute Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Serum Institute Oral Vaccines Products Offered
- 11.5.5 Serum Institute Recent Development
- 11.6 Valneva
- 11.6.1 Valneva Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Valneva Oral Vaccines Products Offered
- 11.6.5 Valneva Recent Development
- 11.7 Shanghai United Cell
- 11.7.1 Shanghai United Cell Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Shanghai United Cell Oral Vaccines Products Offered
- 11.7.5 Shanghai United Cell Recent Development
- 11.8 Bibcol
- 11.8.1 Bibcol Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Bibcol Oral Vaccines Products Offered
- 11.8.5 Bibcol Recent Development
- 11.9 PaxVax
- 11.9.1 PaxVax Company Details
- 11.9.2 Company Business Overview
- 11.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 PaxVax Oral Vaccines Products Offered
- 11.9.5 PaxVax Recent Development
- 11.10 Vabiotech
- 11.10.1 Vabiotech Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Vabiotech Oral Vaccines Products Offered
- 11.10.5 Vabiotech Recent Development
- 11.11 Tiantan Biological
- 11.12 EuBiologics
- 11.13 Panacea Biotec Ltd
- 11.14 Bio-Med
- 11.15 Halfkin Bio-Pharmaceuticals
12 Future Forecast
- 12.1 Oral Vaccines Market Forecast by Regions
- 12.1.1 Global Oral Vaccines Sales Forecast by Regions 2019-2025
- 12.1.2 Global Oral Vaccines Revenue Forecast by Regions 2019-2025
- 12.2 Oral Vaccines Market Forecast by Product
- 12.2.1 Global Oral Vaccines Sales Forecast by Product 2019-2025
- 12.2.2 Global Oral Vaccines Revenue Forecast by Product 2019-2025
- 12.3 Oral Vaccines Market Forecast by End User
- 12.4 North America Oral Vaccines Forecast
- 12.5 Europe Oral Vaccines Forecast
- 12.6 Asia Pacific Oral Vaccines Forecast
- 12.7 Central & South America Oral Vaccines Forecast
- 12.8 Middle East and Africa Oral Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Oral Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Oral Vaccines. Industry analysis & Market Report on Oral Vaccines is a syndicated market report, published as Global Oral Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Oral Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
